Literature DB >> 1563791

Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice.

T Katschinski1, C Galanos, A Coumbos, M A Freudenberg.   

Abstract

Pretreatment of lipopolysaccharide (LPS)-responder C57BL/10ScSn mice with killed Propionibacterium acnes enhanced tumor necrosis factor alpha (TNF-alpha) production and lethality in response to a subsequent challenge with LPS. Sensitization to LPS increased with time of pretreatment and reached its maximum after 7 days. Sensitization was paralleled by gamma interferon (IFN-gamma) production that was detectable from day 3 onward. In contrast, a similar P. acnes pretreatment of LPS-nonresponder C57BL/10ScCr mice had no apparent effect on their high resistance to LPS. Challenge with LPS at any time during the 7-day period after P. acnes treatment led to no detectable TNF-alpha formation and caused no lethal effects. The absence of sensitization in C57BL/10ScCr mice was paralleled by an absence of IFN-gamma production. Administration of monoclonal IFN-gamma antibodies in C57BL/10ScSn mice up to day 3 of P. acnes treatment completely inhibited the overproduction of TNF-alpha by LPS. Anti-IFN-gamma administered later than day 3 had only a partial, although significant, inhibitory effect. Injection of appropriate amounts of anti-IFN-gamma also abolished the development of hypersensitivity to the lethal action of LPS. The effect of exogenously administered IFN-gamma on LPS sensitivity (e.g., TNF-alpha production, lethal effects) was studied in LPS-responder and nonresponder mice. Administration of murine recombinant IFN-gamma increased the sensitivity of C57BL/10ScSn mice to LPS and established LPS responsiveness in LPS-nonresponder C57BL/10ScCr and C3H/HeJ mice. The data provide evidence that IFN-gamma mediates the sensitization towards LPS induced by P. acnes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563791      PMCID: PMC257106          DOI: 10.1128/iai.60.5.1994-2001.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide.

Authors:  G E Gifford; M L Lohmann-Matthes
Journal:  J Natl Cancer Inst       Date:  1987-01       Impact factor: 13.506

Review 2.  Interleukins and the immune system 2.

Authors:  A O'Garra
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.

Authors:  M A Freudenberg; D Keppler; C Galanos
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim.

Authors:  S M Michalek; R N Moore; J R McGhee; D L Rosenstreich; S E Mergenhagen
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

8.  Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.

Authors:  K Kagaya; K Watanabe; Y Fukazawa
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

9.  Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.

Authors:  B Beutler; V Tkacenko; I Milsark; N Krochin; A Cerami
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Gamma interferon prevents the inhibitory effects of oxidative stress on host responses to Escherichia coli infection.

Authors:  M J Parmely; F Wang; D Wright
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component.

Authors:  A Sing; T Merlin; H P Knopf; P J Nielsen; H Loppnow; C Galanos; M A Freudenberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice.

Authors:  P Hochholzer; G B Lipford; H Wagner; K Pfeffer; K Heeg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

Authors:  Marina Gumenscheimer; Ivan Mitov; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.

Authors:  G Tiegs; J Barsig; B Matiba; S Uhlig; A Wendel
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice.

Authors:  Annalisa Lembo; Christoph Kalis; Carsten J Kirschning; Vincenzo Mitolo; Emilio Jirillo; Hermann Wagner; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.

Authors:  Ursula Deiters; Marina Gumenscheimer; Chris Galanos; Peter F Mühlradt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 9.  Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.

Authors:  Manisha Sharma; Polly J Ferguson
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

10.  Tumor necrosis factor alpha and interleukin 6 release induced by antibiotic killing of Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  C M Schneider; D Huzly; C Vetter; B U von Specht; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.